Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
February 6, 2019
Zogenix Submits New Drug Application to U.S. Food & Drug Administration and Marketing Authorization Application to European Medicines Agency for FINTEPLA® for the Treatment of Dravet Syndrome
EMERYVILLE, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a global pharmaceutical company developing rare disease therapies, today announced it has completed its ...
February 6, 2019
Catalyst Biosciences Announces Preclinical Proof-of-Concept Data of Gene Therapy Candidate CB 2679d-GT for the Treatment of Hemophilia B
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
February 6, 2019
Combination of Veyonda® + Radiotherapy Delivers Clinical Benefits In Noxopharm’s DARRT-1 Interim Results
SYDNEY, Australia, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Noxopharm (ASX:NOX) announces interim (12-week) results from the dose-ranging component of the DARRT-1 study. ...
February 6, 2019
Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan
PALO ALTO, Calif., Feb. 6, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, ...
February 6, 2019
Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc.  (BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ...
February 6, 2019
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its ...
February 6, 2019
CytRx Corporation Highlights Positive Results from Full Data Set of Phase 2/3 Clinical Trial in Niemann Pick Disease Type C (NPC) Conducted by Arimoclomol Licensee Orphazyme A/S
LOS ANGELES, Feb. 6, 2019 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, highlighted positive Phase 2/3 clinical trial data ...
February 6, 2019
Quantum Genomics Announces the Publication of Two Scientific Articles Confirming the Efficacy of Firibastat for Heart Failure
PARIS and NEW YORK, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of ...
February 5, 2019
BioInvent CSO to Present F.I.R.S.T.™ Discovery Platform at SLAS2019
LUND, Sweden, Feb. 5, 2019 BioInvent International AB (OMXS:BINV) announces today that its Chief Scientific Officer, Björn Frendéus, will hold a presentation about its phenotypic ...
February 5, 2019
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on February 12
REHOVOT, Israel, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release ...
February 5, 2019
CytoSorbents to Present at the 21st Annual BIO CEO & Investor Conference
MONMOUTH JUNCTION, N.J., Feb. 5, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in ...
February 5, 2019
Catalyst Biosciences to Present at the Annual BIO CEO & Investor Conference
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc., (CBIO) a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
February 5, 2019
Inspire Medical Systems, Inc. Announces Additional Positive Coverage Policies Issued by Five Blue Cross Blue Shield Healthcare Plans
MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
February 5, 2019
EDAP TMS SA : UCI Health Medical Center Becomes First in the U.S. to Treat Patients Using EDAP's Breakthrough Focal One® HIFU Technology
LYON, France, February 5, 2019 -- EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that UCI Health (UCI) has ...
February 5, 2019
Cellectar Biosciences to Present at the Annual BIO CEO & Investor Conference
FLORHAM PARK, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs ...
February 5, 2019
BioLineRx Announces Pricing of $15.4 Million Underwritten Public Offering of its American Depositary Shares and Warrants
TEL AVIV, Israel, Feb. 6, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has priced ...
February 5, 2019
Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States
BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based ...
February 5, 2019
aTyr Pharma to Present at the BIO CEO & Investor Conference
SAN DIEGO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
February 5, 2019
AIT Therapeutics Schedules Fiscal Third Quarter 2019 Financial Results Conference Call and Webcast
NEW YORK, Feb. 05, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
February 5, 2019
Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2018 Financial Results on February 26
MINNEAPOLIS, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
Page 27 of 150